State-of-the-art lymph node staging for breast cancer in the year 2000

Pat Whitworth, Kelly M. McMasters, Lorraine Tafra, Michael J. Edwards

Research output: Contribution to journalArticle

Abstract

Axillary staging for breast cancer is vitally important for determining appropriate adjuvant hormone and chemotherapy. In the absence of distant metastases, axillary lymph node status remains the most accurate predictor of clinical outcome. Sentinel lymph node biopsy is a minimally invasive approach with enhanced accuracy and less morbidity than conventional axillary dissection. The stage is now set for the sentinel lymphadenectomy staging to move from state-of-the-art care to the standard care in coming years. (C) 2000 by Excerpta Medica, Inc.

Original languageEnglish (US)
Pages (from-to)262-267
Number of pages6
JournalAmerican journal of surgery
Volume180
Issue number4
DOIs
StatePublished - Dec 18 2000

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'State-of-the-art lymph node staging for breast cancer in the year 2000'. Together they form a unique fingerprint.

  • Cite this